Status:
RECRUITING
Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
Lead Sponsor:
University of Vienna
Conditions:
Pulmonary Disease
Eligibility:
All Genders
18-100 years
Brief Summary
It is planned to use the CLE probe and cryoprobe simultaneously after detection of the round focus. It is planned to include 5 patients with suspected central airway invading lung carcinoma and 15 pa...
Eligibility Criteria
Inclusion
- \>18 years
- Suspicion of lung carcinoma
Exclusion
- Known allergy to fluorescin
- Pregnancy and/or lactation
- No discontinuation of ß-blocker 12 hours before intervention possible
Key Trial Info
Start Date :
September 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06056882
Start Date
September 20 2023
End Date
June 30 2024
Last Update
February 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria